[IKT] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
16-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 7.95%
YoY- -76.00%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 123 0 7 46 2 328 1,363 -79.79%
PBT -4,279 -4,495 -4,640 -4,641 -5,042 -4,471 -2,636 38.00%
Tax -112 0 -4,640 -4,641 -0 -4,471 -2,628 -87.72%
NP -4,167 -4,495 -4,640 -4,641 -5,042 -4,471 -2,636 35.58%
Tax Rate - - - - - - - -
Total Cost 4,291 4,495 4,646 4,687 5,044 4,800 3,999 4.79%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -3,375.91 0.00 -70,817.14 -10,081.47 -259,342.54 -1,361.26 -193.40 569.41%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.99 -1.06 -1.10 -1.10 -1.20 -1.07 -1.29 -16.13%
EPS Diluted -0.99 -1.06 -1.10 -1.10 -1.20 -1.07 -1.29 -16.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.